Literature DB >> 3403997

Fatal measles pneumonia without rash in a child with AIDS.

L E Markowitz1, F W Chandler, E O Roldan, M J Saldana, K C Roach, S S Hutchins, S R Preblud, C D Mitchell, G B Scott.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3403997     DOI： 10.1093/infdis/158.2.480

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  15 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

Review 2.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

3.  Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Authors:  N Dhiman; I G Ovsyannikova; J E Ryan; R M Jacobson; R A Vierkant; V S Pankratz; S J Jacobsen; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  Vigorous but short-term gamma interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles.

Authors:  Assan Jaye; Carla A Herberts; Sabelle Jallow; Sowsan Atabani; Michel R Klein; Peter Hoogerhout; Michael Kidd; Cécile A C M van Els; Hilton C Whittle
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 5.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Authors:  Inna G Ovsyannikova; Neelam Dhiman; Robert M Jacobson; Robert A Vierkant; Gregory A Poland
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.

Authors:  E Connor; S Morrison; J Lane; J Oleske; R L Sonke; J Connor
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

8.  Characteristics of viruses derived from nude mice with persistent measles virus infection.

Authors:  Yusaku Abe; Koichi Hashimoto; Masahiro Watanabe; Shinichiro Ohara; Masatoki Sato; Yukihiko Kawasaki; Yuko Hashimoto; Mitsuaki Hosoya
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

9.  Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities.

Authors:  Kaitlin Rainwater-Lovett; Hope C Nkamba; Mwangelwa Mubiana-Mbewe; Carolyn Bolton-Moore; William J Moss
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

10.  Preventing secondary infections among HIV-positive persons.

Authors:  G A Filice; C Pomeroy
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.